Shree Sidhbali Biotech Profile
Key Indicators
- Authorised Capital ₹ 3.00 M
as on 15-11-2024
- Paid Up Capital ₹ 2.63 M
as on 15-11-2024
- Company Age 18 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 2.12 Cr
as on 15-11-2024
- Revenue -35.04%
(FY 2023)
- Profit -6047.79%
(FY 2023)
- Ebitda -100.26%
(FY 2023)
- Net Worth -67.76%
(FY 2023)
- Total Assets -27.01%
(FY 2023)
About Shree Sidhbali Biotech
The Company is engaged in the Manufacturing Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 3.00 M and a paid-up capital of Rs 2.63 M.
The company has closed loans amounting to ₹2.12 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Ruchira Maheshwari and Aditya Maheshwari serve as directors at the Company.
- CIN/LLPIN
U15139UR2006PTC032310
- Company No.
032310
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Sep 2006
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Uttarakhand
Industry
Company Details
- Location
Dehradun, Uttarakhand, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Shree Sidhbali Biotech?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Aditya Maheshwari  | Director | 31-May-2021 | Current |
| Ruchira Maheshwari | Director | 05-Nov-2016 | Current |
Financial Performance of Shree Sidhbali Biotech.
Shree Sidhbali Biotech Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 35.04% decrease. The company also saw a substantial fall in profitability, with a 6047.79% decrease in profit. The company's net worth observed a substantial decline by a decrease of 67.76%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Shree Sidhbali Biotech?
In 2023, Shree Sidhbali Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Adhunik Electro Controls Private LimitedActive 17 years 1 month
Aditya Maheshwari is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Canara Bank Creation Date: 01 Jun 2020 | ₹4.41 M | Satisfied |
Canara Bank Creation Date: 04 Mar 2017 | ₹1.68 Cr | Satisfied |
How Many Employees Work at Shree Sidhbali Biotech?
Unlock and access historical data on people associated with Shree Sidhbali Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Shree Sidhbali Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shree Sidhbali Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
